Current and historical daily PE Ratio for Organogenesis Holdings Inc (
) from 2016 to Jun 02 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Organogenesis stock (ORGO) PE ratio as of Jun 02 2024 is 76.25.
More Details
Organogenesis Holdings Inc (ORGO) PE Ratio (TTM) Chart
Organogenesis Holdings Inc (ORGO) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1241
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Organogenesis PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-02 | 76.3 | 2024-03-28 | 78.9 |
| 2024-05-31 | 76.3 | 2024-03-27 | 76.7 |
| 2024-05-30 | 75.8 | 2024-03-26 | 72.8 |
| 2024-05-29 | 71.4 | 2024-03-25 | 72.8 |
| 2024-05-28 | 74.2 | 2024-03-22 | 72.5 |
| 2024-05-24 | 73.1 | 2024-03-21 | 73.9 |
| 2024-05-23 | 74.7 | 2024-03-20 | 77.8 |
| 2024-05-22 | 78.3 | 2024-03-19 | 76.4 |
| 2024-05-21 | 76.9 | 2024-03-18 | 76.4 |
| 2024-05-20 | 76.9 | 2024-03-15 | 79.2 |
| 2024-05-17 | 76.1 | 2024-03-14 | 78.9 |
| 2024-05-16 | 79.2 | 2024-03-13 | 83.3 |
| 2024-05-15 | 82.5 | 2024-03-12 | 81.7 |
| 2024-05-14 | 79.0 | 2024-03-11 | 82.8 |
| 2024-05-13 | 82.2 | 2024-03-08 | 86.4 |
| 2024-05-10 | 84.2 | 2024-03-07 | 86.9 |
| 2024-05-09 | 63.3 | 2024-03-06 | 79.2 |
| 2024-05-08 | 64.2 | 2024-03-05 | 77.2 |
| 2024-05-07 | 67.8 | 2024-03-04 | 80.0 |
| 2024-05-06 | 66.4 | 2024-03-01 | 81.1 |
| 2024-05-03 | 69.2 | 2024-02-29 | 99.2 |
| 2024-05-02 | 69.2 | 2024-02-28 | 96.9 |
| 2024-05-01 | 69.7 | 2024-02-27 | 99.4 |
| 2024-04-30 | 65.3 | 2024-02-26 | 96.9 |
| 2024-04-29 | 68.2 | 2024-02-23 | 96.1 |
| 2024-04-26 | 65.3 | 2024-02-22 | 94.2 |
| 2024-04-25 | 63.5 | 2024-02-21 | 95.3 |
| 2024-04-24 | 82.8 | 2024-02-20 | 95.0 |
| 2024-04-23 | 82.8 | 2024-02-16 | 96.7 |
| 2024-04-22 | 82.5 | 2024-02-15 | 102.2 |
| 2024-04-19 | 80.6 | 2024-02-14 | 102.1 |
| 2024-04-18 | 79.4 | 2024-02-13 | 98.1 |
| 2024-04-17 | 77.5 | 2024-02-12 | 106.7 |
| 2024-04-16 | 79.4 | 2024-02-09 | 101.4 |
| 2024-04-15 | 76.7 | 2024-02-08 | 100.6 |
| 2024-04-12 | 80.0 | 2024-02-07 | 98.9 |
| 2024-04-11 | 83.3 | 2024-02-06 | 95.3 |
| 2024-04-10 | 81.9 | 2024-02-05 | 88.9 |
| 2024-04-09 | 81.1 | 2024-02-02 | 92.5 |
| 2024-04-08 | 82.5 | 2024-02-01 | 95.3 |
| 2024-04-05 | 78.6 | 2024-01-31 | 91.7 |
| 2024-04-04 | 77.8 | 2024-01-30 | 96.9 |
| 2024-04-03 | 76.9 | 2024-01-29 | 101.1 |
| 2024-04-02 | 72.5 | 2024-01-26 | 97.5 |
| 2024-04-01 | 77.8 | 2024-01-25 | 101.4 |
Organogenesis Holdings Inc (ORGO) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Organogenesis Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US68621F1021
Share Class Description:
ORGO: Class ADescription
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers